Company Filing History:
Years Active: 2019-2025
Title: Noriko Iwamoto: Innovator in Monoclonal Antibody Detection
Introduction
Noriko Iwamoto is a prominent inventor based in Kyoto, Japan. She has made significant contributions to the field of monoclonal antibody detection, holding a total of 8 patents. Her innovative work has advanced analytical techniques that are crucial for various applications in biotechnology and medicine.
Latest Patents
Iwamoto's latest patents include a "Kit for preparing sample for detecting monoclonal antibody" and a "Method for improving result monoclonal antibody detection." The sample preparation kit provides a versatile analytical technique that is unaffected by the diversity of antibodies and other variables. It includes a porous body for immobilizing the monoclonal antibody, nanoparticles with immobilized protease, and a filtration membrane for extracting the reaction product. The detection method involves capturing the monoclonal antibody, conducting selective protease digestion, and detecting peptide fragments using liquid chromatography-mass spectrometry (LC-MS). These inventions enhance the applicability of detection methods for monoclonal antibodies.
Career Highlights
Throughout her career, Noriko Iwamoto has worked with esteemed organizations such as Shimadzu Corporation and the National Cancer Center. Her experience in these institutions has allowed her to develop and refine her innovative techniques in antibody detection.
Collaborations
Iwamoto has collaborated with notable colleagues, including Takashi Shimada and Megumi Takanashi. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Noriko Iwamoto's contributions to the field of monoclonal antibody detection exemplify her innovative spirit and dedication to scientific advancement. Her patents and collaborations continue to influence the biotechnology landscape, paving the way for future discoveries.